Compared to CML cells, treated with imatinib only, additional stress induction by oligomycin and thapsigargin triggered apoptosis pathways via the activation of caspase 3 and by inhibition of PARP. The gene discussed is CASP3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.